Zobrazeno 1 - 10
of 343
pro vyhledávání: '"Adi, Diab"'
Autor:
Helen Gogas, Shruthi Ravimohan, Antara Datta, Aparna Chhibber, Eva Muñoz Couselo, Adi Diab, Caio Pereira, Gaëlle Quéreux, Shahneen Sandhu, Brendan Curti, Nikhil I. Khushalani, Matthew H. Taylor, Gregory A. Daniels, Anna Spreafico, Tarek Meniawy, Alfons J. M. Van Den Eertwegh, Yongliang Sun, Yull Arriaga, Ming Zhou, Georgina V. Long, Céleste Lebbé
Publikováno v:
npj Precision Oncology, Vol 8, Iss 1, Pp 1-13 (2024)
Abstract In PIVOT IO 001 (NCT03635983), the combination of the investigational interleukin-2 agonist bempegaldesleukin (BEMPEG) with nivolumab (NIVO) had no added clinical benefit over NIVO monotherapy in unresectable/metastatic melanoma. Pre-defined
Externí odkaz:
https://doaj.org/article/26da8ef263884c9b8a1666837464dce4
Autor:
Sydney A. Keatts, Aya F. Salem, David M. Swanson, Ahsan S. Farooqi, Andrew J. Bishop, Rodabe N. Amaria, Jennifer L. McQuade, Isabella C. Glitza Oliva, Adi Diab, Roi Weiser, Sarah B. Fisher, Ryan P. Goepfert, Merrick I. Ross, B. Ashleigh Guadagnolo, Devarati Mitra
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 49, Iss , Pp 100856- (2024)
Background and purpose: As patients with advanced melanoma live longer in the context of systemic therapy advancements, better strategies for durable control of bulky tumors are needed. In this study, we evaluated if dose-escalated hypofractionated r
Externí odkaz:
https://doaj.org/article/3407e6df315b41fa937429310baf0c92
Autor:
Maria A Lopez-Olivo, Maria E Suarez-Almazor, Gabrielle F Duhon, McKenna Cherry, Huifang Lu, Cassandra Calabrese, Mehmet Altan, Hussain Tawbi, Alexa Meara, Clifton O Bingham, Adi Diab, Viola B Leal, Robert J Volk
Publikováno v:
JMIR Cancer, Vol 10, p e53443 (2024)
BackgroundPatients with cancer and an underlying autoimmune disease who are considering immune checkpoint blockers (ICBs) need to know about the benefits and risks of severe immune-related adverse events and flares of the autoimmune condition. Objec
Externí odkaz:
https://doaj.org/article/f8ca7fd98712473cbeb9c829d394a4e5
Publikováno v:
RMD Open, Vol 10, Iss 3 (2024)
Background Immune checkpoint inhibitors (ICIs) have significantly improved outcomes for patients with cancer. However, these therapies are associated with adverse events including de novo immune-related adverse events or flare of pre-exiting autoimmu
Externí odkaz:
https://doaj.org/article/645c7485a5394d94a0b9d241c919f74f
Autor:
Sang T. Kim, Yanshuo Chu, Mercy Misoi, Maria E. Suarez-Almazor, Jean H. Tayar, Huifang Lu, Maryam Buni, Jordan Kramer, Emma Rodriguez, Zulekha Hussain, Sattva S. Neelapu, Jennifer Wang, Amishi Y. Shah, Nizar M. Tannir, Matthew T. Campbell, Don L. Gibbons, Tina Cascone, Charles Lu, George R. Blumenschein, Mehmet Altan, Bora Lim, Vincente Valero, Monica E. Loghin, Janet Tu, Shannon N. Westin, Aung Naing, Guillermo Garcia-Manero, Noha Abdel-Wahab, Hussein A. Tawbi, Patrick Hwu, Isabella C. Glitza Oliva, Michael A. Davies, Sapna P. Patel, Jun Zou, Andrew Futreal, Adi Diab, Linghua Wang, Roza Nurieva
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-1 (2024)
Externí odkaz:
https://doaj.org/article/c777865947454d67bd544bb4094e3d5f
Autor:
Pankti Reid, Sabina Sandigursky, Juhee Song, Maria A. Lopez-Olivo, Houssein Safa, Samuel Cytryn, Elizaveta Efuni, Maryam Buni, Anna Pavlick, Michelle Krogsgaard, Osama Abu-Shawer, Mehmet Altan, Jeffrey S. Weber, Osama E. Rahma, Maria E. Suarez-Almazor, Adi Diab, Noha Abdel-Wahab
Publikováno v:
OncoImmunology, Vol 12, Iss 1 (2023)
ABSTRACTPatients with preexisting autoimmune disease (pAID) are generally excluded from clinical trials for immune checkpoint inhibitors (ICIs) for cancer due to concern of flaring pAID. In this multi-center, retrospective observational study, we com
Externí odkaz:
https://doaj.org/article/e9e4bf95dfc442469304d1d2730ac304
Autor:
Cassandra Calabrese, Maria E Suarez-Almazor, Robert J Volk, Adi Diab, Mehmet Altan, Viola B Leal, Maria A Lopez-Olivo, Gabrielle F Duhon, McKenna Erck, Hussain Tawbi, Alexa Meara, Clifton Bingham
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/4a2a4a71e9834a0d914be351629d575c
Autor:
Susan Peterson, Maria E Suarez-Almazor, Sanjay Shete, Sapna Patel, Cassian Yee, Adi Diab, Padmanee Sharma, Suhendan Ekmekcioglu, Rodabe Amaria, Isabella Glitza, Noha Abdel-Wahab, Michael K Wong, Jennifer McQuade, Michael A Davies, Salah-Eddine Bentebibel, Reham Abdel-Wahab, Hussain Tawbi, Bilal Anouti, Zaida Gonzales, Christine A Spillson, George P Baum, Joanna-Grace M Manzano, David Tweardy
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/5d00ee8b15a04be3bc16254b7e5f4d6d
Autor:
Evan Hall, Adi Diab, Sajeve Thomas, Randy Sweis, Anthony El-Khoueiry, Naveen K Mehta, Jennifer S Michaelson, Laura Liu, Reham Abdel-Wahab, Jeffrey A Jones, Kaida Wu, Benjamin S Maciejewski
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/3894269b8f7b430fa6dbb37f186f00ac
Autor:
Adi Diab, Suhendan Ekmekcioglu, Noha Abdel-Wahab, Michael A Davies, Julie M Simon, Alexander J Lazar, Jared K Burks, Salah-Eddine Bentebibel, Sungnam Cho, Javier A Gomez, Reham Abdel-Wahab, Jeffrey E Gershenwald
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/031bb837235f4699a6d86f0f37e8c063